General Medicine
An online healthcare store where people compare care options and upfront prices, book visits and order medications or lab tests.
$120MSeries B
ParticipantB
BoxGroup
Activity from announced rounds
Activity in this selectionOct 24, 2026 · Healthtech · Jan 1, 2026
BoxGroup invests at the earliest stages of technology companies, including software, developer tools, marketplaces, fintech, climate and frontier technology.
The firm explicitly includes ideas, experiments and solo founders in its investment scope. A company can therefore fit its stated approach while the founding team is still testing what to build, rather than only after a product and organisation are established.
Sources
- Rounds participated in
- 8
- Confirmed lead rounds
- 0 5 roles undisclosed
- New companies
- 7 First participation on record · 1 follow-on
- Funding in participating rounds
- $674M 8 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
8 in this selectionCorridor
An employee health-benefits brokerage for small and midsize businesses, combining human advisors with AI agents for plan selection and ongoing administration.
$25MSeed
ParticipantFerry Health
Ferry is an AI healthcare-navigation assistant that helps patients find suitable in-network providers and schedule care. It handles the back-and-forth by checking specialty and location fit, contacting provider offices by phone and completing appointment booking by text; it reaches patients through partnerships with health systems and insurers.
$9MSeed
Role not disclosedForus
Connects healthcare providers, pharmacies, payers and biopharma through AI-assisted treatment-access workflows.
$150MSeries C
ParticipantNourish
Provides AI-native metabolic health care with dietitians and virtual medical services
$100MSeries C
Role not disclosedForus
Connects healthcare providers, pharmacies, payers and biopharma through AI-assisted treatment-access workflows.
$160MSeries A
Role not disclosedHelical
Develops virtual AI lab for pharmaceutical research and development
$10MSeed
Role not disclosedLoyal
Loyal develops medicines intended to extend dogs’ lifespans.
$100MSeries C
Role not disclosed